Recursion Pharmaceuticals Cash Flow Statement 2019-2024 | RXRX

Fifteen years of historical annual cash flow statements for Recursion Pharmaceuticals (RXRX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-328.07$-239.48$-186.48$-87.01$-61.88
$24.40$11.76$8.41$3.94$2.49
$66.14$39.28$19.77$6.05$1.94
$90.54$51.03$28.17$9.99$4.43
$0$0$0$0$-0.03
$0$0$0$0$0
$-0.99$1.77$1.75$-0.19$-0.34
$-58.69$103$-15.38$26.33$0.63
$-50.26$105$-0.31$31.62$0.41
$-287.78$-83.52$-158.61$-45.40$-57.04
$-11.96$-37.06$-39.80$-5.83$-3.91
$-0.60$-0.30$0$-0.90$0
$1.84$0$0$-2.60$0
$0.48$231$-231.95$0$0
$0$0$0$0.60$0
$0.48$231$-231.95$0.60$0
$0$0$0$0$0
$-10.23$193$-271.74$-8.74$-3.91
$-0.77$-0.09$-12.80$6.32$0.71
$0$0$0$0$0
$-0.77$-0.09$-12.80$6.32$0.71
$128$144$463$0$0
$128$144$463$239$120
$0$0$0$0$0
$12.81$10.72$8.44$0.68$-0.21
$140$154$459$246$120
$-157.69$264$28.18$192$59.46
$53.50$27.91$14.84$4.29$1.39
$0$0$0$0$0